Free Trial

OptimizeRx (OPRX) SEC Filings & 10K Form

OptimizeRx logo
$4.94 +0.11 (+2.28%)
(As of 12/24/2024 01:48 PM ET)

Recent OptimizeRx SEC Filings

DateFilerForm TypeView
12/23/2024
7:50 AM
OptimizeRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2024
6:46 PM
OptimizeRx (Issuer)
Stelmakh Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
6:47 PM
Besch Doug (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
6:47 PM
OptimizeRx (Issuer)
Silvestro Stephen L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
6:48 PM
Odence-Ford Marion (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
1:28 PM
FEBBO WILLIAM J (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
2:18 PM
AWM Investment Company, Inc. (Filed by)
OptimizeRx (Subject)
Form SC 13G
11/14/2024
10:25 AM
Divisadero Street Capital Management, LP (Filed by)
OptimizeRx (Subject)
Form SC 13G/A
11/13/2024
9:25 AM
OptimizeRx (Subject)
Samjo Management, LLC (Filed by)
Form SC 13G
11/12/2024
8:37 AM
Odence-Ford Marion (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
7:30 PM
Greco Theresa (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
3:53 PM
OptimizeRx (Issuer)
Stelmakh Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2024
8:30 PM
OptimizeRx (Issuer)
Stelmakh Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2024
8:24 PM
Besch Doug (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2024
8:24 PM
OptimizeRx (Issuer)
Silvestro Stephen L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2024
8:26 PM
Odence-Ford Marion (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
3:30 PM
OptimizeRx (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
3:25 PM
OptimizeRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2024
4:22 PM
McCarthy Brian Clark (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2024
3:45 PM
OptimizeRx (Filer)
Form S-8 POS
06/12/2024
10:41 AM
FEBBO WILLIAM J (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
4:47 PM
KLEMA CATHY (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
4:48 PM
HALAS GUS D (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
4:48 PM
OptimizeRx (Issuer)
WASSON GREGORY D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
4:49 PM
OptimizeRx (Issuer)
Vos Ellen O'Connor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
4:50 PM
OptimizeRx (Issuer)
Spangler Patrick D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
4:46 PM
Lang James Paul (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
8:00 AM
First Light Asset Management, LLC (Filed by)
OptimizeRx (Subject)
Form SC 13G/A
05/15/2024
4:01 PM
OptimizeRx (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2024
3:10 PM
OptimizeRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2024
8:32 PM
OptimizeRx (Issuer)
Silvestro Stephen L (Reporting)
Form 4/A
05/06/2024
8:34 PM
OptimizeRx (Issuer)
Silvestro Stephen L (Reporting)
Form 4/A
05/06/2024
8:35 PM
OptimizeRx (Issuer)
Silvestro Stephen L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
7:35 AM
OptimizeRx (Filer)
Form DEF 14A
04/29/2024
7:38 AM
OptimizeRx (Filer)
Form ARS
04/22/2024
7:37 AM
OptimizeRx (Issuer)
Stelmakh Edward (Reporting)
Form 4/A
04/22/2024
7:31 AM
OptimizeRx (Issuer)
Stelmakh Edward (Reporting)
Form 4/A
04/18/2024
3:30 PM
OptimizeRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2024
4:22 PM
FEBBO WILLIAM J (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2024
3:41 PM
OptimizeRx (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/28/2024
7:15 AM
OptimizeRx (Filer)
Form NT 10-K
We recommended Palantir in 2021, now we’re recommending this... (Ad)

My research indicates there is only one investment that can meet AI's unprecedented demand for energy.

Click to get the name and ticker symbol
03/06/2024
3:19 PM
Odence-Ford Marion (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
3:20 PM
OptimizeRx (Issuer)
Silvestro Stephen L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
5:22 PM
OptimizeRx (Issuer)
Silvestro Stephen L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
5:23 PM
Odence-Ford Marion (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
5:24 PM
OptimizeRx (Issuer)
Stelmakh Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
5:25 PM
Besch Doug (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
5:16 PM
Odence-Ford Marion (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2024
6:53 PM
KLEMA CATHY (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
4:04 PM
KLEMA CATHY (Reporting)
OptimizeRx (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/26/2024
3:00 PM
OptimizeRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/18/2024
4:56 PM
FEBBO WILLIAM J (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2024
4:06 PM
Odence-Ford Marion (Reporting)
OptimizeRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
3:28 PM
Odence-Ford Marion (Reporting)
OptimizeRx (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/05/2024
4:19 PM
OptimizeRx (Filer)
Form 8-K/A
12/29/2023
4:30 PM
Divisadero Street Capital Management, LP (Filed by)
OptimizeRx (Subject)
Form SC 13G
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:OPRX) was last updated on 12/25/2024 by MarketBeat.com Staff
From Our Partners